Robert H. Schneider, MD, FACC
November 24th, 2012
Author of Trial on Transcendental Meditation and Heart Disease Responds
Robert H. Schneider, MD, FACC
Dr. Robert H. Schneider, lead author of a recent study on cardiovascular benefits of Transcendental Meditation, responds to Larry Husten’s corrected critique of that study.
February 25th, 2010
Proposed Performance Measures for Hypertension and Stable Coronary Artery Disease Now Available for Public Comment!
Frederick Masoudi, MD, MSPH
The American College of Cardiology and the American Heart Association, collaborating with the American Medical Association’s Physician Consortium for Performance Improvement (PCPI), have drafted an updated set of clinical performance measures for assessing and improving the quality of ambulatory care of patients with hypertension and stable coronary artery disease. These measures, which assess processes of care (e.g., medication prescription) […]
NEJM Journal Watch — Recent Cardiology Articles- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension